Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prophylaxis for venous thromboembolism during treatment for cancer: questionnaire survey.

× No keyword cloud information.

5 in total

Review 1. ABC of antithrombotic therapy: Antithrombotic therapy in special circumstances. II-In children, thrombophilia, and miscellaneous conditions.

Authors: Bernd Jilma; Sridhar Kamath; Gregory Y H Lip
Journal: BMJ Date: 2003-01-11

Review 2. Thromboprophylaxis in the cancer patient.

Authors: P A Thodiyil; D C Walsh; A K Kakkar
Journal: Acta Haematol Date: 2001 Impact factor: 2.195

3. Venous thrombosis during multimodal treatment of primary breast carcinoma.

Authors: R B Weiss; D C Tormey; J F Holland; V E Weinberg
Journal: Cancer Treat Rep Date: 1981 Jul-Aug

4. Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients.

Authors: L T Goodnough; H Saito; A Manni; P K Jones; O H Pearson
Journal: Cancer Date: 1984-10-01 Impact factor: 6.860

5. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors.

Authors: B Fisher; J Costantino; C Redmond; R Poisson; D Bowman; J Couture; N V Dimitrov; N Wolmark; D L Wickerham; E R Fisher
Journal: N Engl J Med Date: 1989-02-23 Impact factor: 91.245

5 in total

16 in total

1. Brief report: graduated compression stocking thromboprophylaxis for elderly inpatients: a propensity analysis.

Authors: Jose Labarere; Jean-Luc Bosson; Marie-Antoinette Sevestre; Anne-Sophie Delmas; Stéphane Dupas; Marie-Hélène Thenault; Annie Legagneux; Gudrun Boge; Béatrice Terriat; Gilles Pernod
Journal: J Gen Intern Med Date: 2006-09-25 Impact factor: 5.128

Review 2. Venous thromboembolic disease and cancer.

Authors: A Fennerty
Journal: Postgrad Med J Date: 2006-10 Impact factor: 2.401

Review 3. The challenges of managing cancer related venous thromboembolism in the palliative care setting.

Authors: S Noble
Journal: Postgrad Med J Date: 2007-11 Impact factor: 2.401

4. When are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English health care data.

Authors: Alex J Walker; Joe West; Tim R Card; Colin Crooks; Cliona C Kirwan; Matthew J Grainge
Journal: Blood Date: 2015-11-16 Impact factor: 22.113

10. FRAGMATIC: a randomised phase III clinical trial investigating the effect of fragmin added to standard therapy in patients with lung cancer.

Authors: Gareth O Griffiths; Sarah Burns; Simon I Noble; Fergus R Macbeth; David Cohen; Timothy S Maughan
Journal: BMC Cancer Date: 2009-10-06 Impact factor: 4.430

Prophylaxis for venous thromboembolism during treatment for cancer: questionnaire survey.

Review 1. ABC of antithrombotic therapy: Antithrombotic therapy in special circumstances. II-In children, thrombophilia, and miscellaneous conditions.

Review 2. Thromboprophylaxis in the cancer patient.

3. Venous thrombosis during multimodal treatment of primary breast carcinoma.

4. Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients.

5. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors.

1. Brief report: graduated compression stocking thromboprophylaxis for elderly inpatients: a propensity analysis.

Review 2. Venous thromboembolic disease and cancer.

Review 3. The challenges of managing cancer related venous thromboembolism in the palliative care setting.

4. When are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English health care data.

Review 5. Prevention of venous thromboembolism in hospitalized patients with cancer.

6. Idiopathic and recurrent thromboembolic phenomena in cancer patients.

Review 7. Cancer and thrombosis: an increasingly important association.

Review 8. Epidemiology and pathophysiology of cancer-associated thrombosis.

9. Platelet release of Vascular Endothelial Growth Factor (VEGF) in patients undergoing chemotherapy for breast cancer.

10. FRAGMATIC: a randomised phase III clinical trial investigating the effect of fragmin added to standard therapy in patients with lung cancer.